Cassava Sciences Inc Stock Price and Quote (2024)

Held by: VTI IWM VXF IWO SCHA XPH VTWO VHT IHE NUSC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.16	Insider Own	6.40%	Shs Outstand	47.98M	Perf Week	-0.25%
Market Cap	954.32M	Forward P/E	55.25	EPS next Y	0.36	Insider Trans	0.00%	Shs Float	44.90M	Perf Month	-14.74%
Income	-47.90M	PEG	-	EPS next Q	-0.41	Inst Own	24.61%	Short Float	27.70%	Perf Quarter	-3.87%
Sales	0.00M	P/S	-	EPS this Y	53.74%	Inst Trans	4.60%	Short Ratio	15.52	Perf Half Y	-32.23%
Book/sh	1.82	P/B	10.94	EPS next Y	133.54%	ROA	-25.63%	Short Interest	12.44M	Perf Year	-22.27%
Cash/sh	2.59	P/C	7.69	EPS next 5Y	-	ROE	-33.90%	52W Range	12.32 - 32.10	Perf YTD	-11.64%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-30.45%	ROI	-60.95%	52W High	-38.04%	Beta	-0.51
Dividend TTM	-	Quick Ratio	1.74	Sales past 5Y	0.00%	Gross Margin	-	52W Low	61.44%	ATR (14)	1.07
Dividend Ex-Date	Dec 13, 2012	Current Ratio	1.74	EPS Y/Y TTM	43.36%	Oper. Margin	0.00%	RSI (14)	43.03	Volatility	4.16% 5.09%
Employees	29	Debt/Eq	0.00	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	104.33
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	26.90%	Payout	-	Rel Volume	0.57	Prev Close	19.07
Sales Surprise	-	EPS Surprise	6.52%	Sales Q/Q	-	Earnings	May 10 AMC	Avg Volume	801.39K	Price	19.89
SMA20	-6.49%	SMA50	-7.92%	SMA200	-7.90%	Trades		Volume	460,770	Change	4.30%

open in yahoo|&nbspopen in reuters|&nbspopen in marketwatch|&nbspopen in google|&nbspopen in EDGAR

Cassava Sciences Inc Stock Price and Quote (1)

Cassava Sciences Inc Stock Price and Quote (2)

Date	Action	Analyst	Rating Change	Price Target Change
Nov-16-22	Downgrade	B. Riley Securities	Buy → Neutral	$44
Jul-15-21	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$100
Jul-07-21	Reiterated	Maxim Group	Buy	$80 → $190
Apr-27-21	Initiated	B. Riley Securities	Buy	$78
Feb-16-21	Reiterated	H.C. Wainwright	Buy	$20 → $66
Oct-23-20	Initiated	Cantor Fitzgerald	Overweight	$24
Sep-23-20	Upgrade	H.C. Wainwright	Neutral → Buy	$20
May-18-20	Downgrade	H.C. Wainwright	Buy → Neutral
May-15-20	Downgrade	Maxim Group	Buy → Hold
Jan-10-20	Reiterated	Maxim Group	Buy	$3 → $12

Cassava Sciences Inc Stock Price and Quote (3)

May-23-24 09:55AM	Cassava Sciences, Inc. (SAVA)'s Technical Outlook is Bright After Key Golden Cross (Zacks)
May-10-24 08:53PM	SAVA Stock Earnings: Cassava Sciences Beats EPS for Q1 2024 (InvestorPlace)
04:02PM	Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam (GlobeNewswire)
May-08-24 11:00AM	Cassava Sciences Announces Over $125 Million Raised from Warrant Distribution (GlobeNewswire)
May-01-24 09:10AM	Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ (GlobeNewswire)
Apr-30-24 01:16PM	Stock Market Crash Warning: Don't Get Caught Holding These 3 Biotech Stocks (InvestorPlace)
Apr-15-24 09:20AM	Redemption Date Announced for Warrants (GlobeNewswire) -12.04%
Mar-25-24 09:13AM	Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials (GlobeNewswire)
Mar-13-24 10:45AM	SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava (PR Newswire)
Mar-04-24 09:15AM	Cassava Sciences Announces Virtual Presentation at the AD/PD 2024 International Conference (GlobeNewswire)
Feb-28-24 09:14AM	Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates (GlobeNewswire)
Feb-23-24 11:30AM	CASSAVA SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Cassava To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Feb-08-24 10:39AM	Cassava Sciences (SAVA) Stock Pops on Positive Results in Simufilam Trial (InvestorPlace)
Feb-07-24 09:08AM	No Decline in Cognition Scores in Patients with Mild Alzheimer's Disease Who Received Simufilam Continuously For 24 Months (GlobeNewswire) +7.35%
Feb-05-24 02:35PM	Cassava Sciences Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information (GlobeNewswire)
Jan-05-24 11:46AM	New SAVAW Warrants Are Trading After Cassava Sciences' Distribution (InvestorPlace)
09:12AM	Cassava Sciences Completes Dividend Distribution of Warrants to Shareholders (GlobeNewswire)
Dec-26-23 05:06AM	3 Growth Stocks Expected to Skyrocket in 2024, According to Wall Street (Motley Fool)
Dec-15-23 06:06PM	Why Cassava Sciences Stock Zoomed 21% Higher This Week (Motley Fool)
Dec-13-23 11:10AM	Cassava Sciences Stock Shows Rising Relative Strength Following 3 Up Days (Investor's Business Daily)
Dec-12-23 02:02PM	Why Is Cassava Sciences (SAVA) Stock Up 15% Today? (InvestorPlace) +5.96%
09:13AM	Cassava Sciences Announces Dividend Distribution of Warrants to Shareholders (GlobeNewswire)
Dec-08-23 07:31PM	Why Cassava Sciences Stock Soared Today (Motley Fool) +17.37%
Dec-07-23 04:01PM	Cassava Sciences Appoints Three New Members to its Board of Directors (GlobeNewswire)
Nov-14-23 09:53PM	7 High-Risk, High-Reward Stocks for the Extreme Contrarian (InvestorPlace) +13.90%
Nov-07-23 09:39AM	Cassava Sciences Inc (SAVA) Reports Q3 2023 Financial Results (GuruFocus.com)
09:01AM	Cassava Sciences Reports Third Quarter 2023 Financial and Operating Results (GlobeNewswire)
Nov-06-23 09:15AM	Cassava Sciences Completes Enrollment for Pivotal Phase 3 Program of Simufilam in Alzheimer's Disease (GlobeNewswire) -5.81%
Oct-31-23 08:15AM	1 Big Red Flag to Fear When a Stock Is Down (Motley Fool) +6.39%
Oct-25-23 09:15AM	MRI Data Suggest Simufilam is Not Associated with Amyloid-related Imaging Abnormalities (ARIA) (GlobeNewswire) +25.80%
Oct-19-23 09:59AM	7 Stocks That Are Heading for a Train Wreck (InvestorPlace) +5.32%
Oct-16-23 07:01PM	Is This The End Of Naked Short Selling? (Oilprice.com) -14.94%
05:26PM	SAVA Stock Continues to Plunge on Misconduct Allegations (InvestorPlace)
Oct-13-23 03:29PM	Cassava Sciences Adviser Found to Have Committed Egregious Misconduct (The Wall Street Journal) -15.28%
03:29PM	Alzheimers Researcher Found to Have Committed Misconduct (The Wall Street Journal)
12:45PM	Why Cassava Sciences Stock Is Tanking Today (Motley Fool)
11:21AM	SAVA Stock Alert: Cassava Sciences Addresses Leaked Report (InvestorPlace)
Oct-12-23 11:43PM	Statement by Cassava Sciences Regarding an Internal CUNY Report Leaked to the Press (GlobeNewswire)
Oct-06-23 03:13PM	Why Shares of Cassava Sciences Soared This Week (Motley Fool)
Oct-05-23 09:15AM	Cassava Sciences to Present at the Jefferies Biotech CNS/Neuro Summit in NY (GlobeNewswire)
Oct-02-23 09:00AM	Cassava Sciences Completes Patient Enrollment for Pivotal Phase 3 Clinical Trial of Oral Simufilam in Alzheimer's Disease (GlobeNewswire)
Sep-18-23 09:15AM	Cassava Sciences Announces Positive Interim Safety Review of Simufilam On-going Phase 3 Trials in Patients with Alzheimers Disease (GlobeNewswire) -5.31%
Sep-14-23 06:30AM	The 7 Best Meme Stocks to Buy Now: September 2023 (InvestorPlace)
Sep-13-23 05:20PM	Cassava Sciences Announces Science Publication That Confirms Mechanism of Action of Simufilam, a Novel Drug Candidate for People with Alzheimers Disease (GlobeNewswire)
Sep-11-23 09:10AM	Cassava Sciences Announces Science Publication That Confirms Mechanism of Action of Simufilam, a Novel Drug Candidate for People with Alzheimers Disease (GlobeNewswire)
Sep-06-23 09:15AM	Cassava Sciences Invited to Present in Four Upcoming Investor Conferences (GlobeNewswire)
Aug-29-23 07:30AM	16 Most Shorted Stocks Right Now (Insider Monkey) +8.87%
Aug-03-23 09:07AM	Cassava Sciences Reports Q2 2023 Financial Results and Operating Updates (GlobeNewswire)
Jul-29-23 11:30AM	Top 12 Small-Cap Stocks With Highest Upside Potential (Insider Monkey)
Jul-13-23 07:31AM	Why These 3 Stocks Are the Worst Ways to Play Biotech Right Now (InvestorPlace)
Jul-05-23 11:44AM	Why Shares of Cassava Sciences Are Dropping Wednesday (Motley Fool) -12.95%
09:15AM	Oral Simufilam Slowed Cognitive Decline in a Randomized Withdrawal Trial of Mild-to-Moderate Alzheimers Disease (GlobeNewswire)
Jun-27-23 09:15AM	New Research Shows Simufilam Suppresses Overactive mTOR (GlobeNewswire)
Jun-12-23 10:19AM	Companies Like Cassava Sciences (NASDAQ:SAVA) Are In A Position To Invest In Growth (Simply Wall St.)
09:15AM	New Publication Highlights Basic Science Supporting Simufilam (GlobeNewswire)
Jun-01-23 09:15AM	Cassava Sciences to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-30-23 12:06PM	Cassava (SAVA) Up on Progress With Alzheimers Disease Study (Zacks)
May-23-23 09:50AM	3 Biotech Stocks to Avoid Like the Plague (InvestorPlace)
May-12-23 04:39PM	Why Shares of Cassava Sciences Jumped This Week (Motley Fool) -5.06%
May-11-23 02:40PM	Cassava Sciences Stock Clears Benchmark, Hitting 80-Plus RS Rating (Investor's Business Daily)
09:15AM	Cassava Sciences Completes Patient Dosing in a Randomized Controlled Trial of Simufilam in Alzheimers Disease (GlobeNewswire)
May-08-23 09:15AM	New Data by Academic Researchers Highlights Biological Activity of Simufilam on Filamin A (GlobeNewswire)
May-01-23 09:00AM	Cassava Sciences Reports Q1 2023 Financial Results and Operating Updates (GlobeNewswire)
Apr-26-23 09:12AM	Cassava Sciences to Present at the 2023 H.C. Wainwright Investor Conference (GlobeNewswire)
Mar-09-23 09:45AM	3 Short-Squeeze Stocks to Keep on Your Radar (InvestorPlace)
Mar-04-23 07:20AM	The three-year returns have been massive for Cassava Sciences (NASDAQ:SAVA) shareholders despite underlying losses increasing (Simply Wall St.)
Mar-03-23 07:07AM	Q4 2022 Lexicon Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-28-23 09:15AM	Cassava Sciences Reports Full-year 2022 Financial Results and Operating Updates (GlobeNewswire)
Feb-24-23 01:29PM	3 Drug Stocks to Watch as Alzheimers Clinical Trials End (InvestorPlace)
Feb-08-23 09:15AM	Cassava Sciences Announces Patient Enrollment Update for Phase 3 Studies of Simufilam for the Treatment of Alzheimers Disease (GlobeNewswire)
Feb-01-23 08:55AM	3 Big Reasons to Sell Cassava Sciences Stock Right Now (Motley Fool)
Jan-25-23 08:27PM	Why the Dip in Cassava Sciences (SAVA) Stock Shouldnt Spook You (TipRanks) -6.62%
Jan-24-23 04:06PM	Cassava Plummets As 'Highly Desirable' Alzheimer's Results Don't Cut It With Investors (Investor's Business Daily) -19.21%
12:22PM	Cassava Sciences Shares Fall On Phase 2 Alzheimer's Trial Results (Benzinga)
09:15AM	Cassava Sciences Announces Positive Top-Line Clinical Results in Phase 2 Study Evaluating Simufilam in Alzheimers Disease (GlobeNewswire)
Jan-18-23 10:35AM	Cassava Sciences Stock Shows Big Jump In Its Relative Strength Rating (Investor's Business Daily)
Jan-12-23 09:40AM	Is Mesa Laboratories (MLAB) Outperforming Other Medical Stocks This Year? (Zacks)
Jan-03-23 09:16AM	Cassava Sciences, Inc. (NASDAQ:SAVA) most popular amongst individual investors who own 69% of the shares, institutions hold 25% (Simply Wall St.) -6.03%
Dec-20-22 09:15AM	Cassava Sciences Mourns the Death of Board Member and Officer Nadav Friedmann, PhD, MD (GlobeNewswire)
Dec-06-22 09:15AM	Cassava Sciences Announces Completion of Dosing in Open-label Study of Simufilam for Alzheimers Disease (GlobeNewswire)
Nov-22-22 12:30PM	Cassava Sciences Announces Closing of $50 Million Registered Direct Offering (GlobeNewswire)
Nov-18-22 01:30PM	Cassava Sciences Announces $50 Million Registered Direct Offering of Common Stock (GlobeNewswire)
Nov-16-22 10:43AM	7 Stocks Rattled by Corporate Scandals and Shenanigans in 2022 (InvestorPlace) -13.04%
Nov-15-22 10:00AM	Lexicon's Experimental Drug Shows Significant, Consistent Benefits In Diabetic Neuropathy Study (Benzinga)
Nov-14-22 03:54PM	Cassava Sciences stock pops after rival experiences setback in Alzheimers research (Yahoo Finance Video) +9.44%
Nov-07-22 09:00AM	Cassava Sciences Reports Third Quarter Financial Results for 2022 andBusiness Updates (GlobeNewswire)
06:15AM	What the Latest Controversy Really Means for SAVA Stock (InvestorPlace)
Nov-04-22 10:49AM	Short sellers hit back at Cassava lawsuit against them: We stand behind everything we wrote (MarketWatch)
Nov-03-22 09:15AM	Cassava Sciences Files Lawsuit Against Perpetrators of Short and Distort Campaign (GlobeNewswire)
Nov-01-22 02:21PM	Cassava Sciences (SAVA) to Report Q3 Earnings: What's in Store? (Zacks)
Oct-31-22 05:50PM	Cassava Sciences, Inc. (SAVA) Dips More Than Broader Markets: What You Should Know (Zacks)
06:15AM	A New Study Makes Cassava Sciences Stock an Interesting Buy (InvestorPlace)
Oct-27-22 09:15AM	Cassava Sciences Announces Expansion of Leadership Team (GlobeNewswire)
Oct-25-22 05:50PM	Cassava Sciences, Inc. (SAVA) Gains But Lags Market: What You Should Know (Zacks)
Oct-17-22 05:50PM	Cassava Sciences, Inc. (SAVA) Stock Sinks As Market Gains: What You Should Know (Zacks)
Oct-13-22 09:15AM	Cassava Sciences Announces Initiation of an Open-label Extension Study (GlobeNewswire)
Oct-11-22 06:00PM	Cassava Sciences, Inc. (SAVA) Dips More Than Broader Markets: What You Should Know (Zacks)
06:00AM	Dont Let Misconduct Allegations Cloud Your Perception of SAVA Stock (InvestorPlace)
Oct-05-22 06:15AM	2 Signals to Watch Before Buying SAVA Stock (InvestorPlace)
Sep-30-22 10:35AM	How High Can SAVA Stock Go Once the Controversy Clears? (InvestorPlace)

Cassava Sciences Inc Stock Price and Quote (4)

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer's disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

Cassava Sciences Inc Stock Price and Quote (5)

Cassava Sciences Inc Stock Price and Quote (6)

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ROBERTSON SANFORD	Director	Apr 26 '24	Option Exercise	22.00	69,000	1,518,000	955,851	Apr 30 09:13 AM
Barry Richard	Director	Apr 23 '24	Option Exercise	22.00	176,085	3,873,870	469,562	Apr 25 09:15 AM
Kupiec James William	Chief Medical Officer	Apr 18 '24	Option Exercise	22.00	1,500	33,000	4,000	Apr 22 09:19 AM
Schoen Eric	Chief Financial Officer	Apr 17 '24	Option Exercise	22.00	1,500	33,000	21,300	Apr 17 04:21 PM
ROBERTSON SANFORD	Director	Aug 23 '23	Buy	17.45	30,000	523,500	886,851	Aug 24 04:06 PM
Barry Richard	Director	Aug 22 '23	Buy	16.65	16,571	275,907	293,477	Aug 23 04:58 PM
Barry Richard	Director	Aug 21 '23	Buy	16.80	1,906	32,021	276,906	Aug 23 04:58 PM

Upgrade your FINVIZ experience

Join thousands of traders who make more informed decisions withourpremium features. Real-time quotes, advancedvisualizations, backtesting, and much more.

Learn more about FINVIZ*Elite